Moderna suffers weak session with 1.16% loss; downside halted at $149.1

A quick look at Friday: during Friday's session, Moderna Inc toiled and struggled for upward momentum before closing at $150.02. By the close, the the mRNA medicines developer suffered a $1.76 or 1.16% loss.

Moderna was not the only decliner in the health care sector; Merck lost 3.02% Friday and closed at $104.1. Abbott Laboratories lost 2.04% Friday and closed at $97. Amgen descends 2.04% Friday to close at $234.57.

Pointing downwards for around 2 months. The mRNA medicines developer is now trading 27.74% below the significant high of $210.04 it set around 2 months ago.